basileapharma.biz basileapharma.biz

BASILEAPHARMA.BIZ

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

http://www.basileapharma.biz/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR BASILEAPHARMA.BIZ

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

April

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 17 reviews
5 star
9
4 star
6
3 star
2
2 star
0
1 star
0

Hey there! Start your review of basileapharma.biz

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

FAVICON PREVIEW

  • basileapharma.biz

    16x16

CONTACTS AT BASILEAPHARMA.BIZ

Basilea Pharmaceutica Ltd

Domain Admin

Grenzac●●●●●●●sse 487

Ba●●el

Ba●●el , BS, 4005

Switzerland CH

41.6●●●●1111
41.6●●●●1112
do●●●●●●●●●@basileapharma.com

View this contact

Basilea Pharmaceutica Ltd

Domain Admin

Grenzac●●●●●●●sse 487

Ba●●el

Ba●●el , BS, 4005

Switzerland CH

41.6●●●●1111
41.6●●●●1112
do●●●●●●●●●@basileapharma.com

View this contact

Netnames USA Billing

NetNam●●●●●●A Inc.

430 W.●●●●●● # 401

New●●●ork , NY 10014

United States US

44.2●●●●4599
44.2●●●●5744
bi●●●●●@netnamesusa.com

View this contact

NetNames USA Inc.

Netnames USA Hostmaster

NetNam●●●●●●A Inc.

430 W.●●●●●● # 401

New●●●ork , NY 10014

United States US

44.2●●●●4599
44.2●●●●5744
te●●@netnamesusa.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
n/a
EXPIRATION
n/a

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns1.netnames.net
2
ns2.netnames.net

REGISTRAR

ASCIO TECHNOLOGIES, INC. DANMARK – FILIAL AF ASCIO TECHNOLOGIES, INC. USA
NETBENEFIT D/B/A NETNAMES

ASCIO TECHNOLOGIES, INC. DANMARK – FILIAL AF ASCIO TECHNOLOGIES, INC. USA NETBENEFIT D/B/A NETNAMES

WHOIS : whois.neulevel.biz

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
Basilea Pharmaceutica - Home | basileapharma.biz Reviews
<META>
DESCRIPTION
Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...
<META>
KEYWORDS
1 biotechnology company
2 discovery
3 development
4 novel drugs
5 unmet medical needs
6 anti-bacterials
7 anti-fungals
8 dermatology
9
10 coupons
CONTENT
Page content here
KEYWORDS ON
PAGE
site map,quick links,e mail distribution,ad hoc notices,financial reports,corporate calendar,corporate,corporate information,board of directors,dr martin nicklasson,mr domenico scala,prof daniel lew,dr thomas werner,board committees,management committee
SERVER
Apache
POWERED BY
PHP/5.5.9-1ubuntu4.17
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Basilea Pharmaceutica - Home | basileapharma.biz Reviews

https://basileapharma.biz

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

OTHER SITES

basileandbasile.com.au basileandbasile.com.au

Home :: Basile & Basile Accounting Firm Gold Coast

Are you looking for a local Gold Coast accounting firm that understands the accounting needs of Gold Coast businesses and individuals? Basile and Basile is situated at the northern end of the Gold Coast click here. To view our location map and we can help you with all you accounting. If you are interested in learning more about our accounting services click here. Or if you would like to find out how Basile and Basile on the Gold Coast can help you get the most out of your tax returns click here.

basileandpape.com basileandpape.com

Basile & Pape

0 Item(s) - $0.00. Your shopping tote is empty!

basileandpape.tumblr.com basileandpape.tumblr.com

BASILE&PAPE Bespoke Jewelry

Bespoke jewelry designed by Robin Basile and Metalsmith John Pape. Fiocina Earrings •• BASILE&PAPE bespoke jewelry. Hinged Serpente Ring by BASILE&PAPE bespoke jewelry.

basileandrea.net basileandrea.net

- BasileAndrea.net

basileanticapasticceria.it basileanticapasticceria.it

Prodotti Dolciari da Forno tipici del Salento - Pasticceria da Forno

Prodotti dolciari da Forno tipici del Salento - Pasticceria da Forno - Prodotti Dolciari. PRODOTTI DOLCIARI - PASTICCERIA DA FORNO DAL 1889. FIOR DÌ MANDORL A. Prodotti - Pasta di Mandorle. Croccante alle Mandorle Bianche. Croccante alle Mandorle Nere. I Tondi al Cioccolato. Ricci di Mandorla alle Cigliege Rosse. Ricci di Mandorla al Caffè. Ricci di Mandorla alle Mandorle. Ricci di Mandorla alle Cigliege Verdi. Ricci di Mandorla al Cacao a Mandorle. Ricci di Mandorla Misti. Ricci di Mandorla Quaresimali.

basileapharma.biz basileapharma.biz

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

basileapharma.com basileapharma.com

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

basileapharma.info basileapharma.info

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

basileapharma.net basileapharma.net

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

basileapharma.org basileapharma.org

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...

basileapharma.us basileapharma.us

Basilea Pharmaceutica - Home

Mr Hans-Beat Gürtler. Dr Thomas M. Rinderknecht. Mr Steven D. Skolsky. Transparence des liens d’intérêt. How to find us. Investor Relations / Media. Rsaquo;› go! Go to Annual report 2014. Link to Share Information. Monday, May 04. 2015. Basilea reports start of first-in-human phase 1 oncology study with oral panRAF kinase inhibitor. Wednesday, April 29. 2015. Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders. Basel, Switzerland...